Common use of Rights in Material Clause in Contracts

Rights in Material. 12.1 Recipient and Researcher acknowledge that ownership of the Product shall remain with CTK. Any Progeny generated by Recipient or Researcher from the Product shall also be owned by CTK. Title to any Derivative shall be with Recipient, except for the nanobodies which shall be owned by CTK. Should in specific cases the CTK nanobodies are not separable from the Derivatives, then Recipient and CTK shall be co-owners of such Derivatives. 12.2 Upon termination of the research work of Researcher, the Product and any Progeny thereof shall be destructed, and Recipient shall certify to CTK in writing as to such destruction. After Researcher has accomplished his/her research with the Product or for other reasons stops working with the Product, Recipient shall ensure that the Product and all Progenies will be destroyed, and Recipient shall certify so to CTK in writing. 12.3 Recipient shall retain all right, title and interest in and the unrestricted right to use all results generated by use of the Material, as well as the right to publish or otherwise disclose such results, provided that CTK is named as the source of the Product and intellectual property holder of the nanobody sequence in the Product in any written or oral publications. 12.4 Recipient hereby grants CTK an non-exclusive, irrevocable, royalty-free, worldwide, sublicensable license for any internal research use of all Derivatives.

Rights in Material. 12.1 Recipient and Researcher acknowledge that ownership of the Product shall remain with CTK. Any Progeny generated by Recipient or Researcher from the Product shall also be owned by CTK. Title to any Derivative shall be with Recipient, except for the nanobodies which shall be owned by CTK. Should in specific cases the CTK nanobodies are not separable from the Derivatives, then Recipient and CTK shall be co-owners of such Derivatives. 12.2 Upon termination of the research work of Researcher, the Product and any Progeny thereof shall be destructed, and Recipient shall certify to CTK in writing as to such destruction. After Researcher has accomplished his/her research with the Product or for other reasons stops working with the Product, Recipient shall ensure that the Product and all Progenies will be destroyed, and Recipient shall certify so to CTK in writing. 12.3 Recipient shall retain all right, title and interest in and the unrestricted right to use all results generated by use of the Material, as well as the right to publish or otherwise disclose such results, provided that (i) CTK is named as the source of the Product and intellectual property holder of the nanobody sequence in the Product and (ii) ) JCB Vol. 290, No. 18 pp. 11209-11216, May 1, 2015 by Xxxx. Xxxxxx Xxxxxx is referenced in any written or oral publications. 12.4 Recipient hereby grants CTK an non-exclusive, irrevocable, royalty-free, worldwide, sublicensable license for any internal research use of all Derivatives.